CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Open-market sale Director sold 7,712 shares at $48.45 ($373,646)
- 4 Open-market sale Director sold 20,634 shares at $46.00 ($949,164)
- 4 Open-market sale Director sold 60,000 shares at $45.71 ($2,742,600)
- 4 Gift President and CEO gave 109,676 shares (gift)
- 4 Grant or award EVP, Research and Development acquired 52,018 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 52,018 shares (grant or award)
- 4 Grant or award SVP and General Counsel acquired 23,119 shares (grant or award)
- 4 Grant or award EVP, Commercial acquired 40,459 shares (grant or award)
- 4 Grant or award President and CEO acquired 160,437 shares (grant or award)
- 4 Open-market sale EVP, Research and Development sold 47,918 shares at $44.50 ($2,132,351)
- 4 Open-market sale EVP, Research and Development sold 29,873 shares at $44.35 ($1,324,868)
- 4 Planned sale Director sold 99,574 shares at $44.01 ($4,382,252)
- 4 Open-market sale Director sold 106,539 shares at an average $44.00 ($4,687,346)
- 4 Open-market sale EVP and CFO sold 64,895 shares at an average $43.32 ($2,810,998)
- 4 Open-market sale EVP, Commercial sold 67,814 shares at an average $43.52 ($2,950,941)
- 4 Shares withheld for taxes President and CEO gave up 489,996 shares (to pay taxes)
- 4 Planned sale Director sold 3,856 shares at $43.79 ($168,854)
- 4 Shares withheld for taxes EVP, Research and Development gave up 39,205 shares (to pay taxes)
- 4 Open-market sale Director sold 30,250 shares at an average $43.81 ($1,325,339)
- 4 Planned sale SVP and General Counsel sold 18,669 shares at $44.01 ($821,623)
Page 2 of 73 · 1,458 filings